Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study.


Journal

Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099

Informations de publication

Date de publication:
05 2021
Historique:
pubmed: 9 10 2020
medline: 1 6 2021
entrez: 8 10 2020
Statut: ppublish

Résumé

In this prospective cohort of 1,012 Swiss hospital employees, 3 different assays were used to screen serum for SARS-CoV-2 antibodies. Seropositivity was 1%; the positive predictive values of the lateral-flow immunoassay were 64% (IgG) and 13% (IgM). History of fever and myalgia most effectively differentiated seropositive and seronegative participants.

Identifiants

pubmed: 33028454
pii: S0899823X20012441
doi: 10.1017/ice.2020.1244
pmc: PMC7582018
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Immunoglobulin M 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

604-608

Auteurs

Philipp P Kohler (PP)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Christian R Kahlert (CR)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.
Children's Hospital of Eastern Switzerland, Department of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Johannes Sumer (J)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Domenica Flury (D)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Sabine Güsewell (S)

Clinical Trials Unit, Cantonal Hospital of St Gallen, St Gallen, Switzerland.

Onicio B Leal-Neto (OB)

Epitrack, Recife, Brazil.
Department of Economics, University of Zurich, Zurich, Switzerland.

Julia Notter (J)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Werner C Albrich (WC)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Baharak Babouee Flury (B)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Allison McGeer (A)

Sinai Health System, Toronto, Ontario, Canada.

Stefan Kuster (S)

Federal Office of Public Health, Berne, Switzerland.

Lorenz Risch (L)

Labormedizinisches Zentrum Dr. Risch, Buchs, Switzerland.

Matthias Schlegel (M)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Pietro Vernazza (P)

Cantonal Hospital St Gallen, Division of Infectious Diseases and Hospital Epidemiology, St Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH